Stay updated on Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added Naples, Italy, 80131; removed Napoli, Italy, 80131; Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-24T12:56:28.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Status updated to Completed with new registry identifiers (UTN and EU CT) and the actual completion date added. New data-sharing links were added and outdated EngageZone links were removed.
    Difference
    0.2%
    Check dated 2026-03-17T07:52:55.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-10T03:00:42.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now displays a revision tag updated to Revision: v3.4.2, replacing Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-16T16:01:12.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision 3.4.1 was added; the previous funding/operating-status notice associated with Revision 3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-09T12:30:59.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated UI labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus a new 'Revision: v3.4.0' tag.
    Difference
    0.1%
    Check dated 2026-01-26T07:52:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.